The cardiologist and smoking cessation

被引:20
作者
Aboyans, Victor [1 ]
Thomas, Daniel [2 ]
Lacroix, Philippe [1 ]
机构
[1] Dupuytren Univ Hosp, Dept Thorac & Cardiovasc Surg & Vasc Med, F-87042 Limoges, France
[2] Hop La Pitie Salpetriere, Dept Med Cardiol, Inst Cardiol, Paris, France
关键词
cardiovascular; counseling; prevention; smoking; tobacco; SUSTAINED-RELEASE BUPROPION; CARDIOVASCULAR RISK-FACTORS; ARTERY-BYPASS-SURGERY; MYOCARDIAL-INFARCTION; TRANSDERMAL NICOTINE; 52; COUNTRIES; DISEASE; PREVENTION; SMOKERS; IMPACT;
D O I
10.1097/HCO.0b013e32833cd4f7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review Among the modifiable risk factors, smoking contributes strongly to the global epidemics of cardiovascular disease morbidity and mortality. In patients with cardiovascular disease, the benefits of smoking cessation outperform those expected from other preventive strategies such as blood pressure or cholesterol control. In-hospital interventions to assist cardiovascular disease patients with smoking cessation and to provide adequate follow-up are the most cost-effective strategies to improve the survival of the cardiovascular patient. Recent findings Data on cardiologists' interest in increasing smoking cessation rates are limited and alarming. Surveys assessing the knowledge, interest and attitudes of cardiologists regarding smoking cessation assistance highlight poor commitment to this important preventive practice. For a substantial proportion of cardiologists, smoking-cessation assistance is not included in their core activities and they do not consider themselves as the most appropriate person for this purpose. Disappointingly, many of them never refer their smoking patients to specialized centers and/or teams for appropriate assistance. Summary The substantial benefits of smoking cessation in cardiovascular prevention requires stronger commitment from cardiologists to provide smoking-cessation therapies and counseling. Further research is needed to highlight the barriers to improve clinical performance by cardiologists in this field of prevention.
引用
收藏
页码:469 / 477
页数:9
相关论文
共 61 条
[1]   Risk factors for progression of peripheral arterial disease in large and small vessels [J].
Aboyans, Victor ;
Criqui, Michael H. ;
Denenberg, Julie O. ;
Knoke, James D. ;
Ridker, Paul M. ;
Fronek, Arnost .
CIRCULATION, 2006, 113 (22) :2623-2629
[2]   Knowledge and management of smoking-cessation strategies among cardiologists in France: A nationwide survey [J].
Aboyans, Victor ;
Pinet, Pauline ;
Lacroix, Philippe ;
Laskar, Marc .
ARCHIVES OF CARDIOVASCULAR DISEASES, 2009, 102 (03) :193-199
[3]   Personal health habits of American cardiologists [J].
Abuissa, H ;
Lavie, C ;
Spertus, J ;
O'Keefe, J .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (07) :1093-1096
[4]   The pathophysiology of cigarette C-V smoking and cardiovascular disease - An update [J].
Ambrose, JA ;
Barua, RS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (10) :1731-1737
[5]  
[Anonymous], PERIPHERAL ARTERIAL
[6]  
[Anonymous], 2002, morbidity and mortality weekly report, V51, P642
[7]   Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial [J].
Aubin, H-J ;
Bobak, A. ;
Britton, J. R. ;
Oncken, C. ;
Billing, C. B., Jr. ;
Gong, J. ;
Williams, K. E. ;
Reeves, K. R. .
THORAX, 2008, 63 (08) :717-724
[8]   Cardiovascular effects of secondhand smoke - Nearly as large as smoking [J].
Barnoya, J ;
Glantz, SA .
CIRCULATION, 2005, 111 (20) :2684-2698
[9]   Psychosocial interventions for smoking cessation in patients with coronary heart disease [J].
Barth, J. ;
Critchley, J. ;
Bengel, J. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01)
[10]   Improved smoking cessation in smokers given ultrasound photographs of their own atherosclerotic plaques [J].
Bovet, P ;
Perret, F ;
Cornuz, J ;
Quilindo, J ;
Paccaud, F .
PREVENTIVE MEDICINE, 2002, 34 (02) :215-220